

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 5.35251043 |
| 2 | doxorubicin metabolic process (GO:0044598) | 5.35251043 |
| 3 | daunorubicin metabolic process (GO:0044597) | 5.35251043 |
| 4 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.25498373 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 4.21108469 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.17601847 |
| 7 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.10651328 |
| 8 | immunoglobulin mediated immune response (GO:0016064) | 3.94919383 |
| 9 | response to peptidoglycan (GO:0032494) | 3.75308991 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.68888242 |
| 11 | negative regulation of cell killing (GO:0031342) | 3.68888242 |
| 12 | cytidine metabolic process (GO:0046087) | 3.62034584 |
| 13 | cytidine catabolic process (GO:0006216) | 3.62034584 |
| 14 | cytidine deamination (GO:0009972) | 3.62034584 |
| 15 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.58720387 |
| 16 | detection of bacterium (GO:0016045) | 3.56633255 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.54865751 |
| 18 | detection of other organism (GO:0098543) | 3.51420609 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.45758061 |
| 20 | keratan sulfate catabolic process (GO:0042340) | 3.43183011 |
| 21 | signal peptide processing (GO:0006465) | 3.41215708 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.38524237 |
| 23 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.38524237 |
| 24 | positive regulation of antigen processing and presentation (GO:0002579) | 3.36801680 |
| 25 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.35542618 |
| 26 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.35542618 |
| 27 | modulation by symbiont of host immune response (GO:0052553) | 3.35542618 |
| 28 | positive regulation by symbiont of host defense response (GO:0052509) | 3.35542618 |
| 29 | modulation by symbiont of host defense response (GO:0052031) | 3.35542618 |
| 30 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.35542618 |
| 31 | response to muramyl dipeptide (GO:0032495) | 3.34524459 |
| 32 | regulation of antigen processing and presentation (GO:0002577) | 3.22776719 |
| 33 | respiratory burst (GO:0045730) | 3.20264405 |
| 34 | negative regulation of phagocytosis (GO:0050765) | 3.15719122 |
| 35 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.14805237 |
| 36 | microglial cell activation (GO:0001774) | 3.14391993 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 3.13732087 |
| 38 | neutrophil activation (GO:0042119) | 3.13688566 |
| 39 | phagocytosis, engulfment (GO:0006911) | 3.12081882 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.05161410 |
| 41 | regulation of response to osmotic stress (GO:0047484) | 2.99237180 |
| 42 | granulocyte activation (GO:0036230) | 2.98765722 |
| 43 | negative regulation of bone resorption (GO:0045779) | 2.98439714 |
| 44 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.97936484 |
| 45 | amyloid precursor protein catabolic process (GO:0042987) | 2.95590781 |
| 46 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.95579174 |
| 47 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.94460516 |
| 48 | positive regulation of chemokine secretion (GO:0090197) | 2.94059955 |
| 49 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.92971839 |
| 50 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.90519630 |
| 51 | regulation of mast cell degranulation (GO:0043304) | 2.90478968 |
| 52 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.87897908 |
| 53 | barbed-end actin filament capping (GO:0051016) | 2.87559104 |
| 54 | B cell mediated immunity (GO:0019724) | 2.87335160 |
| 55 | pinocytosis (GO:0006907) | 2.86667642 |
| 56 | macrophage activation involved in immune response (GO:0002281) | 2.85585715 |
| 57 | regulation of chemokine secretion (GO:0090196) | 2.84734690 |
| 58 | myeloid dendritic cell differentiation (GO:0043011) | 2.81526898 |
| 59 | positive thymic T cell selection (GO:0045059) | 2.79857787 |
| 60 | regulation of leukocyte degranulation (GO:0043300) | 2.79713812 |
| 61 | leukocyte aggregation (GO:0070486) | 2.79368148 |
| 62 | positive regulation of interferon-alpha production (GO:0032727) | 2.78379958 |
| 63 | positive regulation of defense response to virus by host (GO:0002230) | 2.78233096 |
| 64 | detection of external biotic stimulus (GO:0098581) | 2.78185749 |
| 65 | cyclooxygenase pathway (GO:0019371) | 2.74443439 |
| 66 | interferon-gamma production (GO:0032609) | 2.73857952 |
| 67 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.73506579 |
| 68 | regulation of T cell tolerance induction (GO:0002664) | 2.73295802 |
| 69 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.71804553 |
| 70 | regulation of superoxide anion generation (GO:0032928) | 2.70811096 |
| 71 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.69287576 |
| 72 | NIK/NF-kappaB signaling (GO:0038061) | 2.68411657 |
| 73 | maintenance of protein location in nucleus (GO:0051457) | 2.65756106 |
| 74 | regulation of tolerance induction (GO:0002643) | 2.65528042 |
| 75 | regulation of interferon-alpha production (GO:0032647) | 2.62260876 |
| 76 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.62144171 |
| 77 | nucleoside transmembrane transport (GO:1901642) | 2.60744791 |
| 78 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.60683689 |
| 79 | negative regulation of interleukin-2 production (GO:0032703) | 2.59008894 |
| 80 | positive regulation of B cell differentiation (GO:0045579) | 2.57498048 |
| 81 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.55541521 |
| 82 | response to host immune response (GO:0052572) | 2.55100759 |
| 83 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.55100759 |
| 84 | thymic T cell selection (GO:0045061) | 2.54458076 |
| 85 | hyaluronan catabolic process (GO:0030214) | 2.54336151 |
| 86 | amino sugar catabolic process (GO:0046348) | 2.53734515 |
| 87 | myeloid cell activation involved in immune response (GO:0002275) | 2.53188897 |
| 88 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.53119717 |
| 89 | mannose metabolic process (GO:0006013) | 2.53016089 |
| 90 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.52628658 |
| 91 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.52196111 |
| 92 | glycosphingolipid catabolic process (GO:0046479) | 2.51002059 |
| 93 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.49404108 |
| 94 | oligosaccharide catabolic process (GO:0009313) | 2.48843382 |
| 95 | negative thymic T cell selection (GO:0045060) | 2.48404804 |
| 96 | regulation of podosome assembly (GO:0071801) | 2.47825207 |
| 97 | somite rostral/caudal axis specification (GO:0032525) | 2.47323482 |
| 98 | ribosomal small subunit biogenesis (GO:0042274) | 2.45915554 |
| 99 | defense response to protozoan (GO:0042832) | 2.45702664 |
| 100 | response to host (GO:0075136) | 2.45652675 |
| 101 | response to host defenses (GO:0052200) | 2.45652675 |
| 102 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.45652675 |
| 103 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.45262990 |
| 104 | negative regulation of tissue remodeling (GO:0034104) | 2.45019256 |
| 105 | negative regulation of interleukin-6 production (GO:0032715) | 2.43391788 |
| 106 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.42702693 |
| 107 | reactive oxygen species biosynthetic process (GO:1903409) | 2.41815831 |
| 108 | T cell selection (GO:0045058) | 2.41794900 |
| 109 | regulation of B cell differentiation (GO:0045577) | 2.41302146 |
| 110 | germinal center formation (GO:0002467) | 2.41123139 |
| 111 | response to protozoan (GO:0001562) | 2.40166087 |
| 112 | dendritic cell differentiation (GO:0097028) | 2.39991069 |
| 113 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.39757427 |
| 114 | negative regulation of innate immune response (GO:0045824) | 2.39217031 |
| 115 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.38258297 |
| 116 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.37820328 |
| 117 | negative T cell selection (GO:0043383) | 2.36586024 |
| 118 | glycoside metabolic process (GO:0016137) | 2.36276831 |
| 119 | GDP-mannose metabolic process (GO:0019673) | 2.36052288 |
| 120 | response to interferon-beta (GO:0035456) | 2.36045658 |
| 121 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.35851574 |
| 122 | T cell migration (GO:0072678) | 2.35666792 |
| 123 | detection of biotic stimulus (GO:0009595) | 2.35161844 |
| 124 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.35160634 |
| 125 | COPI coating of Golgi vesicle (GO:0048205) | 2.35106826 |
| 126 | Golgi transport vesicle coating (GO:0048200) | 2.35106826 |
| 127 | negative regulation of telomerase activity (GO:0051974) | 2.34488172 |
| 128 | cellular response to interferon-gamma (GO:0071346) | 2.34054996 |
| 129 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.34010570 |
| 130 | B cell receptor signaling pathway (GO:0050853) | 2.33641291 |
| 131 | T-helper 1 type immune response (GO:0042088) | 2.33396545 |
| 132 | cellular extravasation (GO:0045123) | 2.33195838 |
| 133 | positive regulation of interleukin-17 production (GO:0032740) | 2.32839755 |
| 134 | regulation of necroptotic process (GO:0060544) | 2.31717449 |
| 135 | myeloid dendritic cell activation (GO:0001773) | 2.31445060 |
| 136 | actin nucleation (GO:0045010) | 2.31412039 |
| 137 | glycolipid catabolic process (GO:0019377) | 2.31084856 |
| 138 | cellular response to type I interferon (GO:0071357) | 2.31063322 |
| 139 | type I interferon signaling pathway (GO:0060337) | 2.31063322 |
| 140 | peptide catabolic process (GO:0043171) | 2.30555482 |
| 141 | negative regulation of bone remodeling (GO:0046851) | 2.30398170 |
| 142 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.30235717 |
| 143 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.30235717 |
| 144 | regulation of defense response to virus by virus (GO:0050690) | 2.29726542 |
| 145 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.29318798 |
| 146 | ceramide catabolic process (GO:0046514) | 2.29175146 |
| 147 | regulation of macrophage chemotaxis (GO:0010758) | 2.29117128 |
| 148 | negative regulation of epidermis development (GO:0045683) | 2.28657499 |
| 149 | hormone catabolic process (GO:0042447) | 2.28476278 |
| 150 | response to type I interferon (GO:0034340) | 2.27384937 |
| 151 | leukotriene metabolic process (GO:0006691) | 2.26315751 |
| 152 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.26227426 |
| 153 | regulation of RIG-I signaling pathway (GO:0039535) | 2.25595212 |
| 154 | cellular response to interferon-beta (GO:0035458) | 2.25508440 |
| 155 | muscle organ morphogenesis (GO:0048644) | 2.25464046 |
| 156 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.22589717 |
| 157 | negative regulation of granulocyte differentiation (GO:0030853) | 2.21572629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.44289304 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.92529398 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.69750940 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.07083748 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.94729450 |
| 6 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.89423109 |
| 7 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.89423109 |
| 8 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.89423109 |
| 9 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.61859926 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50566698 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.39541984 |
| 12 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.37910163 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.26927027 |
| 14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.26899909 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.16863072 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10253236 |
| 17 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.10153021 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.07725492 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.04547221 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.97621706 |
| 21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.87435194 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86516740 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.82269386 |
| 24 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80561816 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.79296420 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76828055 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.73065594 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.72123268 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68618343 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.67906286 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.65876435 |
| 32 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64688421 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.64189336 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.63185544 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.62806595 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62247192 |
| 37 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.61167139 |
| 38 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.60801388 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59613500 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59472266 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.58581781 |
| 42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.55597675 |
| 43 | * MYB_26560356_Chip-Seq_TH2_Human | 1.55246991 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54527235 |
| 45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.54094975 |
| 46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.50397629 |
| 47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.49135650 |
| 48 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.48283162 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44307721 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44181006 |
| 51 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41999682 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41658539 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40149806 |
| 54 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.38647724 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37629463 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.37540055 |
| 57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36866383 |
| 58 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34379290 |
| 59 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33809893 |
| 60 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.31209539 |
| 61 | * MYB_26560356_Chip-Seq_TH1_Human | 1.31151227 |
| 62 | * MAF_26560356_Chip-Seq_TH1_Human | 1.30200733 |
| 63 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.29931806 |
| 64 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28471690 |
| 65 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26784464 |
| 66 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.26217876 |
| 67 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24783835 |
| 68 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.24307479 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24109967 |
| 70 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.22250589 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.22082781 |
| 72 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21021067 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19169143 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18887694 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16643599 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16631434 |
| 77 | MYC_22102868_ChIP-Seq_BL_Human | 1.16036883 |
| 78 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.15657673 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15017360 |
| 80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14132179 |
| 81 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13239179 |
| 82 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13081385 |
| 83 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.12663833 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12084431 |
| 85 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12032318 |
| 86 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11971977 |
| 87 | P68_20966046_ChIP-Seq_HELA_Human | 1.11624714 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10932485 |
| 89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10628958 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10216586 |
| 91 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10126828 |
| 92 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09240873 |
| 93 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.08478346 |
| 94 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08309097 |
| 95 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08307251 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08262853 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05244409 |
| 98 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03537134 |
| 99 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.02680641 |
| 100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02110588 |
| 101 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01986187 |
| 102 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01698261 |
| 103 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01228834 |
| 104 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00357238 |
| 105 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00156681 |
| 106 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.00084619 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00041442 |
| 108 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.99825637 |
| 109 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98848362 |
| 110 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.97692299 |
| 111 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.97245181 |
| 112 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.95357738 |
| 113 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.94376610 |
| 114 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92740011 |
| 115 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.91612935 |
| 116 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90951175 |
| 117 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.90776202 |
| 118 | MAF_26560356_Chip-Seq_TH2_Human | 0.90360412 |
| 119 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90232556 |
| 120 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.90079208 |
| 121 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.89673600 |
| 122 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88047522 |
| 123 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87995322 |
| 124 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.85589558 |
| 125 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85533162 |
| 126 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84315548 |
| 127 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.83762293 |
| 128 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.83458652 |
| 129 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.83384674 |
| 130 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.83289310 |
| 131 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82857764 |
| 132 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82700736 |
| 133 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.82605849 |
| 134 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82133747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.78458331 |
| 2 | MP0002254_reproductive_system_inflammat | 3.10414072 |
| 3 | MP0006082_CNS_inflammation | 3.04934127 |
| 4 | MP0003436_decreased_susceptibility_to | 2.87971344 |
| 5 | MP0005671_abnormal_response_to | 2.67311947 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.60726689 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.58206888 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.52590023 |
| 9 | MP0000685_abnormal_immune_system | 2.38386849 |
| 10 | MP0004264_abnormal_extraembryonic_tissu | 2.37606062 |
| 11 | MP0005387_immune_system_phenotype | 2.37218930 |
| 12 | MP0001790_abnormal_immune_system | 2.37218930 |
| 13 | MP0009785_altered_susceptibility_to | 2.31135603 |
| 14 | MP0003183_abnormal_peptide_metabolism | 2.29918142 |
| 15 | MP0005025_abnormal_response_to | 2.29633431 |
| 16 | MP0002419_abnormal_innate_immunity | 2.28271713 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.15205052 |
| 18 | MP0001800_abnormal_humoral_immune | 2.14588150 |
| 19 | MP0005451_abnormal_body_composition | 2.12689432 |
| 20 | MP0003011_delayed_dark_adaptation | 2.06738309 |
| 21 | MP0002723_abnormal_immune_serum | 2.02895096 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.00518165 |
| 23 | MP0001819_abnormal_immune_cell | 1.95385129 |
| 24 | MP0002420_abnormal_adaptive_immunity | 1.95294592 |
| 25 | MP0003724_increased_susceptibility_to | 1.83934635 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 1.82635963 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.82378007 |
| 28 | MP0005310_abnormal_salivary_gland | 1.73845614 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.73321662 |
| 30 | MP0002139_abnormal_hepatobiliary_system | 1.71323285 |
| 31 | MP0002405_respiratory_system_inflammati | 1.70874880 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.70727881 |
| 33 | MP0008260_abnormal_autophagy | 1.70240525 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.69546892 |
| 35 | MP0002277_abnormal_respiratory_mucosa | 1.68604572 |
| 36 | MP0001853_heart_inflammation | 1.67115185 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.63960257 |
| 38 | MP0003806_abnormal_nucleotide_metabolis | 1.53887327 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.53463437 |
| 40 | MP0000490_abnormal_crypts_of | 1.51311914 |
| 41 | MP0000343_altered_response_to | 1.49214791 |
| 42 | MP0000716_abnormal_immune_system | 1.48815112 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.47292538 |
| 44 | MP0003303_peritoneal_inflammation | 1.47088018 |
| 45 | MP0009278_abnormal_bone_marrow | 1.44299568 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.41361728 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.36411057 |
| 48 | MP0002398_abnormal_bone_marrow | 1.34432754 |
| 49 | MP0004947_skin_inflammation | 1.32805683 |
| 50 | MP0005257_abnormal_intraocular_pressure | 1.32454846 |
| 51 | MP0008469_abnormal_protein_level | 1.28563436 |
| 52 | MP0002429_abnormal_blood_cell | 1.28405097 |
| 53 | MP0002877_abnormal_melanocyte_morpholog | 1.27942283 |
| 54 | MP0010234_abnormal_vibrissa_follicle | 1.26954752 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.26378689 |
| 56 | MP0004782_abnormal_surfactant_physiolog | 1.26162573 |
| 57 | MP0000858_altered_metastatic_potential | 1.25290322 |
| 58 | MP0002722_abnormal_immune_system | 1.24623827 |
| 59 | MP0009840_abnormal_foam_cell | 1.23765611 |
| 60 | MP0005166_decreased_susceptibility_to | 1.21059880 |
| 61 | MP0005360_urolithiasis | 1.20855050 |
| 62 | MP0001348_abnormal_lacrimal_gland | 1.19694903 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.19400796 |
| 64 | MP0002166_altered_tumor_susceptibility | 1.18885997 |
| 65 | MP0003448_altered_tumor_morphology | 1.17795747 |
| 66 | MP0000604_amyloidosis | 1.15003979 |
| 67 | MP0001851_eye_inflammation | 1.13413703 |
| 68 | MP0001873_stomach_inflammation | 1.12267044 |
| 69 | MP0000678_abnormal_parathyroid_gland | 1.09979549 |
| 70 | MP0004381_abnormal_hair_follicle | 1.08380638 |
| 71 | MP0004510_myositis | 1.08034311 |
| 72 | MP0005365_abnormal_bile_salt | 1.07471211 |
| 73 | MP0002933_joint_inflammation | 1.04792331 |
| 74 | MP0005390_skeleton_phenotype | 1.00509248 |
| 75 | MP0001663_abnormal_digestive_system | 0.99954804 |
| 76 | MP0003186_abnormal_redox_activity | 0.94810579 |
| 77 | MP0002998_abnormal_bone_remodeling | 0.94653282 |
| 78 | MP0010352_gastrointestinal_tract_polyps | 0.94154063 |
| 79 | MP0003705_abnormal_hypodermis_morpholog | 0.92403410 |
| 80 | MP0002098_abnormal_vibrissa_morphology | 0.91748213 |
| 81 | MP0009643_abnormal_urine_homeostasis | 0.91303907 |
| 82 | MP0009763_increased_sensitivity_to | 0.90332672 |
| 83 | MP0005023_abnormal_wound_healing | 0.89330216 |
| 84 | MP0003795_abnormal_bone_structure | 0.88722490 |
| 85 | MP0002006_tumorigenesis | 0.87022499 |
| 86 | MP0003866_abnormal_defecation | 0.86500051 |
| 87 | MP0005165_increased_susceptibility_to | 0.86085500 |
| 88 | MP0005164_abnormal_response_to | 0.84774437 |
| 89 | MP0003075_altered_response_to | 0.81968922 |
| 90 | MP0009764_decreased_sensitivity_to | 0.81419385 |
| 91 | MP0008057_abnormal_DNA_replication | 0.81228725 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.81129338 |
| 93 | MP0002138_abnormal_hepatobiliary_system | 0.81022802 |
| 94 | MP0005501_abnormal_skin_physiology | 0.79943076 |
| 95 | MP0004858_abnormal_nervous_system | 0.79825816 |
| 96 | MP0000609_abnormal_liver_physiology | 0.79819385 |
| 97 | MP0008007_abnormal_cellular_replicative | 0.79554585 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.79440713 |
| 99 | MP0006054_spinal_hemorrhage | 0.78228350 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.78204670 |
| 101 | MP0002132_abnormal_respiratory_system | 0.77981088 |
| 102 | MP0000383_abnormal_hair_follicle | 0.77382172 |
| 103 | MP0001666_abnormal_nutrient_absorption | 0.76294796 |
| 104 | MP0004883_abnormal_blood_vessel | 0.75507065 |
| 105 | MP0000920_abnormal_myelination | 0.75193080 |
| 106 | MP0002796_impaired_skin_barrier | 0.74156193 |
| 107 | MP0003566_abnormal_cell_adhesion | 0.73876235 |
| 108 | MP0003690_abnormal_glial_cell | 0.73726045 |
| 109 | MP0001216_abnormal_epidermal_layer | 0.73672312 |
| 110 | MP0000249_abnormal_blood_vessel | 0.73052838 |
| 111 | MP0005381_digestive/alimentary_phenotyp | 0.71561894 |
| 112 | MP0004808_abnormal_hematopoietic_stem | 0.70552928 |
| 113 | MP0006292_abnormal_olfactory_placode | 0.70212489 |
| 114 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.69898196 |
| 115 | MP0008004_abnormal_stomach_pH | 0.69438480 |
| 116 | MP0003693_abnormal_embryo_hatching | 0.67543113 |
| 117 | MP0004043_abnormal_pH_regulation | 0.66155530 |
| 118 | MP0000377_abnormal_hair_follicle | 0.65322012 |
| 119 | MP0005174_abnormal_tail_pigmentation | 0.63991078 |
| 120 | MP0001849_ear_inflammation | 0.62380100 |
| 121 | MP0000703_abnormal_thymus_morphology | 0.60896656 |
| 122 | MP0004957_abnormal_blastocyst_morpholog | 0.60856411 |
| 123 | MP0003828_pulmonary_edema | 0.60266989 |
| 124 | MP0001545_abnormal_hematopoietic_system | 0.58648639 |
| 125 | MP0005397_hematopoietic_system_phenotyp | 0.58648639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 5.18444626 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.75027603 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.38585213 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.38585213 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.38585213 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.36883999 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.08447502 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.93906239 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.91428636 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.55288343 |
| 11 | Reduced antithrombin III activity (HP:0001976) | 3.31560270 |
| 12 | Myositis (HP:0100614) | 3.26641332 |
| 13 | Type I transferrin isoform profile (HP:0003642) | 3.22280211 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.19074686 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.07301147 |
| 16 | Glomerulonephritis (HP:0000099) | 2.97663832 |
| 17 | Multiple enchondromatosis (HP:0005701) | 2.96911201 |
| 18 | Dysostosis multiplex (HP:0000943) | 2.95717866 |
| 19 | Mucopolysacchariduria (HP:0008155) | 2.90488725 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.90488725 |
| 21 | Bilateral microphthalmos (HP:0007633) | 2.81616827 |
| 22 | Recurrent skin infections (HP:0001581) | 2.81218151 |
| 23 | Petechiae (HP:0000967) | 2.76057346 |
| 24 | Orchitis (HP:0100796) | 2.75507073 |
| 25 | IgM deficiency (HP:0002850) | 2.74913390 |
| 26 | Abnormal protein glycosylation (HP:0012346) | 2.67730812 |
| 27 | Abnormal glycosylation (HP:0012345) | 2.67730812 |
| 28 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.67730812 |
| 29 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.67730812 |
| 30 | Stomatitis (HP:0010280) | 2.67608793 |
| 31 | Nasal polyposis (HP:0100582) | 2.67519391 |
| 32 | Epistaxis (HP:0000421) | 2.53797455 |
| 33 | Gingivitis (HP:0000230) | 2.53765125 |
| 34 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51909412 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51909412 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51909412 |
| 37 | Malnutrition (HP:0004395) | 2.51045206 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 2.50878520 |
| 39 | Partial duplication of thumb phalanx (HP:0009944) | 2.49828078 |
| 40 | Chronic otitis media (HP:0000389) | 2.49277567 |
| 41 | Progressive neurologic deterioration (HP:0002344) | 2.47538251 |
| 42 | Recurrent viral infections (HP:0004429) | 2.44253609 |
| 43 | Cellulitis (HP:0100658) | 2.43101825 |
| 44 | Vertebral compression fractures (HP:0002953) | 2.41798750 |
| 45 | Abnormality of the nasal mucosa (HP:0000433) | 2.38529795 |
| 46 | Increased serum ferritin (HP:0003281) | 2.38131241 |
| 47 | Poor head control (HP:0002421) | 2.37966829 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.35014734 |
| 49 | Recurrent fungal infections (HP:0002841) | 2.34706398 |
| 50 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.31553139 |
| 51 | Cheilitis (HP:0100825) | 2.30900746 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29941123 |
| 53 | Obstructive lung disease (HP:0006536) | 2.29300954 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.29300954 |
| 55 | Gingival bleeding (HP:0000225) | 2.29104917 |
| 56 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.20191039 |
| 57 | Villous atrophy (HP:0011473) | 2.20191039 |
| 58 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.16127559 |
| 59 | Interstitial pulmonary disease (HP:0006530) | 2.15579463 |
| 60 | Partial duplication of the phalanx of hand (HP:0009999) | 2.13467409 |
| 61 | Cervical subluxation (HP:0003308) | 2.13454949 |
| 62 | Vasculitis (HP:0002633) | 2.13040597 |
| 63 | Autoimmune thrombocytopenia (HP:0001973) | 2.12968037 |
| 64 | Trismus (HP:0000211) | 2.10039824 |
| 65 | Pustule (HP:0200039) | 2.08872217 |
| 66 | Gastrointestinal infarctions (HP:0005244) | 2.08617887 |
| 67 | Periodontitis (HP:0000704) | 2.08293997 |
| 68 | Gastrointestinal inflammation (HP:0004386) | 2.07508400 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.07203171 |
| 70 | Chest pain (HP:0100749) | 2.06679650 |
| 71 | Optic neuritis (HP:0100653) | 2.05365231 |
| 72 | Retrobulbar optic neuritis (HP:0100654) | 2.05365231 |
| 73 | Hepatosplenomegaly (HP:0001433) | 2.04220836 |
| 74 | Loss of speech (HP:0002371) | 2.03122636 |
| 75 | Abnormality of iron homeostasis (HP:0011031) | 2.03096960 |
| 76 | Hypertensive crisis (HP:0100735) | 2.02502749 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.01012488 |
| 78 | Thrombocytosis (HP:0001894) | 2.00977041 |
| 79 | Thoracic kyphosis (HP:0002942) | 2.00487718 |
| 80 | Inflammation of the large intestine (HP:0002037) | 2.00181742 |
| 81 | Reticulocytopenia (HP:0001896) | 1.97062798 |
| 82 | T lymphocytopenia (HP:0005403) | 1.96324307 |
| 83 | Gastrointestinal stroma tumor (HP:0100723) | 1.95656451 |
| 84 | Abnormality of complement system (HP:0005339) | 1.95567072 |
| 85 | Mediastinal lymphadenopathy (HP:0100721) | 1.95499715 |
| 86 | Encephalitis (HP:0002383) | 1.95474516 |
| 87 | Hemorrhage of the eye (HP:0011885) | 1.93801422 |
| 88 | Prolonged neonatal jaundice (HP:0006579) | 1.93600093 |
| 89 | Meningitis (HP:0001287) | 1.93363180 |
| 90 | Rib fusion (HP:0000902) | 1.92593694 |
| 91 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.92441070 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 1.92173662 |
| 93 | Purpura (HP:0000979) | 1.91510581 |
| 94 | Colitis (HP:0002583) | 1.90917775 |
| 95 | Premature loss of primary teeth (HP:0006323) | 1.90499941 |
| 96 | Recurrent bronchitis (HP:0002837) | 1.90439623 |
| 97 | Urticaria (HP:0001025) | 1.88948201 |
| 98 | Hemoptysis (HP:0002105) | 1.88748011 |
| 99 | Abnormality of T cell number (HP:0011839) | 1.88747679 |
| 100 | Recurrent cutaneous fungal infections (HP:0011370) | 1.87970086 |
| 101 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.87970086 |
| 102 | Complement deficiency (HP:0004431) | 1.87807816 |
| 103 | Restrictive lung disease (HP:0002091) | 1.87238377 |
| 104 | Spontaneous hematomas (HP:0007420) | 1.86899272 |
| 105 | Upper limb muscle weakness (HP:0003484) | 1.85672743 |
| 106 | Chronic diarrhea (HP:0002028) | 1.85254490 |
| 107 | Skin ulcer (HP:0200042) | 1.85150326 |
| 108 | J-shaped sella turcica (HP:0002680) | 1.83463785 |
| 109 | Abnormal number of erythroid precursors (HP:0012131) | 1.83165749 |
| 110 | Agammaglobulinemia (HP:0004432) | 1.83036967 |
| 111 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.82915942 |
| 112 | Hypoplasia of the fovea (HP:0007750) | 1.82915942 |
| 113 | Polygenic inheritance (HP:0010982) | 1.82310931 |
| 114 | Skin rash (HP:0000988) | 1.81570180 |
| 115 | Axonal loss (HP:0003447) | 1.81558349 |
| 116 | Increased IgM level (HP:0003496) | 1.80158227 |
| 117 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.80123773 |
| 118 | Basal ganglia calcification (HP:0002135) | 1.79185802 |
| 119 | Polycythemia (HP:0001901) | 1.78495435 |
| 120 | Bone pain (HP:0002653) | 1.77547634 |
| 121 | Amyloidosis (HP:0011034) | 1.77485963 |
| 122 | Recurrent pneumonia (HP:0006532) | 1.77364598 |
| 123 | Granulocytopenia (HP:0001913) | 1.76603064 |
| 124 | Disinhibition (HP:0000734) | 1.76253288 |
| 125 | Leukocytosis (HP:0001974) | 1.76070894 |
| 126 | Distal lower limb muscle weakness (HP:0009053) | 1.75558901 |
| 127 | Eosinophilia (HP:0001880) | 1.74421656 |
| 128 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.72910575 |
| 129 | Osteomyelitis (HP:0002754) | 1.71518868 |
| 130 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.71285225 |
| 131 | Abnormality of T cells (HP:0002843) | 1.70840240 |
| 132 | Rectovaginal fistula (HP:0000143) | 1.70807359 |
| 133 | Rectal fistula (HP:0100590) | 1.70807359 |
| 134 | Ulnar deviation of the wrist (HP:0003049) | 1.70087533 |
| 135 | Increased IgE level (HP:0003212) | 1.69924592 |
| 136 | Pulmonary embolism (HP:0002204) | 1.68531788 |
| 137 | Hypertriglyceridemia (HP:0002155) | 1.66591047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.54994438 |
| 2 | TGFBR2 | 3.91437566 |
| 3 | BLK | 3.05823938 |
| 4 | CSF1R | 3.03934581 |
| 5 | CDK12 | 2.88023790 |
| 6 | IRAK4 | 2.63064426 |
| 7 | PRPF4B | 2.48247683 |
| 8 | STK10 | 2.39805399 |
| 9 | IRAK3 | 2.31221906 |
| 10 | SMG1 | 2.28108736 |
| 11 | TRIB3 | 2.20647445 |
| 12 | MAP4K1 | 2.20527591 |
| 13 | GRK6 | 2.18683109 |
| 14 | EPHB1 | 2.05909285 |
| 15 | TYK2 | 2.01877574 |
| 16 | MAP3K14 | 1.88702949 |
| 17 | IKBKB | 1.88041630 |
| 18 | KIT | 1.86334338 |
| 19 | MATK | 1.83343853 |
| 20 | GRK7 | 1.82796369 |
| 21 | TBK1 | 1.71665181 |
| 22 | MAP3K11 | 1.71176276 |
| 23 | GRK1 | 1.67391397 |
| 24 | SIK1 | 1.65696797 |
| 25 | ADRBK2 | 1.62994126 |
| 26 | MST4 | 1.62163478 |
| 27 | MAPK15 | 1.61973509 |
| 28 | MAP3K3 | 1.61083250 |
| 29 | GRK5 | 1.59748945 |
| 30 | BTK | 1.53191525 |
| 31 | TAOK2 | 1.52582597 |
| 32 | CSK | 1.52303889 |
| 33 | PAK4 | 1.46373089 |
| 34 | ITK | 1.44444183 |
| 35 | SIK3 | 1.42182591 |
| 36 | NME2 | 1.41037579 |
| 37 | TAOK1 | 1.37655024 |
| 38 | PIM2 | 1.34078743 |
| 39 | MAPK7 | 1.33313823 |
| 40 | ZAP70 | 1.29862043 |
| 41 | IRAK2 | 1.26883885 |
| 42 | TNK2 | 1.24212168 |
| 43 | TEC | 1.24061987 |
| 44 | MOS | 1.23643126 |
| 45 | MAP3K13 | 1.23132734 |
| 46 | MAP2K3 | 1.17204734 |
| 47 | MAP3K1 | 1.16977927 |
| 48 | IKBKE | 1.13521002 |
| 49 | JAK3 | 1.12136732 |
| 50 | CHUK | 1.10957967 |
| 51 | CCNB1 | 1.10636670 |
| 52 | PRKG2 | 1.07505062 |
| 53 | NME1 | 1.01880323 |
| 54 | RIPK1 | 1.01330635 |
| 55 | HIPK2 | 0.99363984 |
| 56 | CDC42BPA | 0.95645397 |
| 57 | MAP3K10 | 0.88523190 |
| 58 | LCK | 0.88370077 |
| 59 | SCYL2 | 0.87708851 |
| 60 | LYN | 0.85986583 |
| 61 | SYK | 0.84890784 |
| 62 | ICK | 0.83739175 |
| 63 | JAK1 | 0.83537205 |
| 64 | TXK | 0.83316123 |
| 65 | PRKD2 | 0.83258444 |
| 66 | PDPK1 | 0.81907299 |
| 67 | MAP2K2 | 0.81346908 |
| 68 | LRRK2 | 0.81137050 |
| 69 | FGR | 0.75627821 |
| 70 | TAOK3 | 0.75288070 |
| 71 | HCK | 0.74830086 |
| 72 | CLK1 | 0.74800618 |
| 73 | EIF2AK2 | 0.73272775 |
| 74 | EPHA2 | 0.71941459 |
| 75 | PDK1 | 0.70791549 |
| 76 | MAP2K6 | 0.70652492 |
| 77 | MAPKAPK2 | 0.70557775 |
| 78 | NEK9 | 0.68688372 |
| 79 | MAPK11 | 0.67881228 |
| 80 | PIK3CG | 0.67401649 |
| 81 | NLK | 0.67371623 |
| 82 | IRAK1 | 0.67103286 |
| 83 | VRK1 | 0.65547178 |
| 84 | WNK1 | 0.64461967 |
| 85 | ARAF | 0.63038920 |
| 86 | FLT3 | 0.60653251 |
| 87 | MAP3K8 | 0.59199095 |
| 88 | CDK7 | 0.59036863 |
| 89 | FGFR3 | 0.58167770 |
| 90 | BCKDK | 0.58044817 |
| 91 | VRK2 | 0.57091603 |
| 92 | PIM1 | 0.56984281 |
| 93 | PRKCD | 0.56885440 |
| 94 | JAK2 | 0.56601899 |
| 95 | TTK | 0.56312711 |
| 96 | MARK3 | 0.55138350 |
| 97 | ABL2 | 0.54692771 |
| 98 | MAPKAPK3 | 0.54673338 |
| 99 | PBK | 0.52600132 |
| 100 | TYRO3 | 0.51480863 |
| 101 | RPS6KL1 | 0.50940429 |
| 102 | RPS6KC1 | 0.50940429 |
| 103 | TRPM7 | 0.50803828 |
| 104 | PKN2 | 0.50365063 |
| 105 | IGF1R | 0.50296995 |
| 106 | CDK6 | 0.49215443 |
| 107 | EIF2AK3 | 0.49084622 |
| 108 | RIPK4 | 0.48085322 |
| 109 | TESK1 | 0.47502006 |
| 110 | DYRK1B | 0.47479754 |
| 111 | DDR2 | 0.46492561 |
| 112 | RPS6KA4 | 0.45097068 |
| 113 | MAP3K2 | 0.44726060 |
| 114 | BMX | 0.43793790 |
| 115 | ABL1 | 0.43323246 |
| 116 | RPS6KA2 | 0.42814070 |
| 117 | MAPK4 | 0.42320256 |
| 118 | DAPK1 | 0.41332065 |
| 119 | TESK2 | 0.41054240 |
| 120 | MAPK12 | 0.40905564 |
| 121 | FGFR4 | 0.40304879 |
| 122 | KSR2 | 0.39098025 |
| 123 | GSK3A | 0.38407110 |
| 124 | FES | 0.37624791 |
| 125 | CDK4 | 0.36628829 |
| 126 | PTK6 | 0.36228947 |
| 127 | FYN | 0.36206171 |
| 128 | EEF2K | 0.34952741 |
| 129 | BMPR2 | 0.34886610 |
| 130 | STK4 | 0.34716073 |
| 131 | KDR | 0.32254226 |
| 132 | EPHA3 | 0.31842215 |
| 133 | MAPKAPK5 | 0.31123894 |
| 134 | PASK | 0.31009189 |
| 135 | CAMK4 | 0.30610696 |
| 136 | YES1 | 0.28703243 |
| 137 | MST1R | 0.27938743 |
| 138 | PAK1 | 0.27497505 |
| 139 | PRKCQ | 0.26612422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.11012171 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.18364604 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.17238105 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 2.26256534 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.25216815 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.14965579 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.09236537 |
| 8 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.00783813 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96912419 |
| 10 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.88001259 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.86720128 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79504673 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.76807069 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.68271886 |
| 15 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.67027894 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.64761293 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.57656283 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.56894369 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.54837168 |
| 20 | Ribosome_Homo sapiens_hsa03010 | 1.54415009 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52239150 |
| 22 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.47390233 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.46187044 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.43273590 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.41148318 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.36206561 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.34071952 |
| 28 | Galactose metabolism_Homo sapiens_hsa00052 | 1.31343070 |
| 29 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.31149880 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.28367791 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.26859635 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.21052422 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.20238046 |
| 34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.20153726 |
| 35 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.18435358 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.15985483 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.14441891 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13254747 |
| 39 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.10873399 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 1.10743983 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.10725603 |
| 42 | Tuberculosis_Homo sapiens_hsa05152 | 1.10653126 |
| 43 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.07219283 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.07209520 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.06746693 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05429244 |
| 47 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.04530059 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.04170533 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03696998 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03553740 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 1.01576674 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97448179 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96802318 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.94073472 |
| 55 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.93770325 |
| 56 | Asthma_Homo sapiens_hsa05310 | 0.93143487 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90064166 |
| 58 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.89372094 |
| 59 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88417962 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.83577625 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78902001 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.76902550 |
| 63 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.75079731 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.73222476 |
| 65 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72648707 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72029383 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.71824661 |
| 68 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70882087 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70674753 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70085197 |
| 71 | Bladder cancer_Homo sapiens_hsa05219 | 0.69228361 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68896103 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68156519 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68120220 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.67852168 |
| 76 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66787888 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.66057579 |
| 78 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.65638617 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64838134 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.64768221 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.63539423 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.62794934 |
| 83 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.61446362 |
| 84 | RNA polymerase_Homo sapiens_hsa03020 | 0.60496164 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60284999 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58775500 |
| 87 | Base excision repair_Homo sapiens_hsa03410 | 0.58486785 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56552357 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55931481 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.55710148 |
| 91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55386942 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54827755 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53491456 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52331479 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51343759 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50501643 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50182635 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49724259 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48760636 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46870130 |
| 101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46790660 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.46240734 |
| 103 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46176282 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.46121035 |
| 105 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46060367 |
| 106 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45788767 |
| 107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.45379282 |
| 108 | Proteasome_Homo sapiens_hsa03050 | 0.43794729 |
| 109 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43613123 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43251467 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.42967159 |
| 112 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42336756 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42294165 |
| 114 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42271220 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41719376 |
| 116 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39930408 |
| 117 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.39710037 |
| 118 | DNA replication_Homo sapiens_hsa03030 | 0.39504151 |
| 119 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39259887 |
| 120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38847802 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38665341 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38046422 |
| 123 | ABC transporters_Homo sapiens_hsa02010 | 0.37338465 |
| 124 | Homologous recombination_Homo sapiens_hsa03440 | 0.37190099 |
| 125 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.36578473 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33877841 |
| 127 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32042610 |
| 128 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29488021 |

